Pharmacological relapse prevention in alcohol dependence: From animal models to clinical trials

Alcoholism: Clinical and Experimental Research

Volumn 25, Issue 5 SUPPL., 2001, Pages

  Boening, Jobst August Ludwig ^a   Lesch, Otto Michel ^a,b   Spanagel, Rainer ^a,c   Wolffgramm, Jochen ^a,d   Narita, Minoru ^a,e   Sinclair, David ^a,f   Mason, Barbara J ^a,g   Wiesbeck, Gerhard A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e HOSHI UNIVERSITY   (Japan)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol Addiction; Animal Models; Naltrexone; NMDA; Protein Kinase C

Indexed keywords

ACAMPROSATE; ALCOHOL; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPENTIXOL; IFENPRODIL; LISURIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALMEFENE; NALOXONE; NALTREXONE; PROTEIN KINASE C; RECEPTOR SUBUNIT; SEROTONIN AGONIST;

ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL TRIAL; CONFERENCE PAPER; FOLLOW UP; HUMAN; JAPAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; SYMPOSIUM; TREATMENT OUTCOME; VALIDATION PROCESS;

ANIMALIA;

EID: 0034965644     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2001.tb02386.x     Document Type: Conference Paper

References (36)

1. Naltrexone and cognitive behavioral therapy for the treatment of out-patient alcoholics: Results of a placebo-controlled trial
2. Naltrexone and brief counseling to reduce heavy drinking
3. Tianeptine and alcohol dependence
4. Efficacy of naltrexone in the prevention of alcohol relapses: Results from a German multicenter study
5. Targeted naltrexone with coping therapy for controlled drinking, without prior detoxification, is effective and particularly well tolerated: An 8-month controlled trial
6. Persisting consequences of drug intake: Towards a memory of addiction
7. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure
8. Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats
9. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
10. Acamprosate in alcohol dependence: How does it work?
11. Six-month follow-up of interaction effect between naltrexone and coping skills therapy in out-patient alcoholism treatment
12. Animal models of drug craving
13. Alcohol preference in the rat: Reduction following depletion of brain serotonin
14. Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain
15. Long-acting injectable bromocriptine does not reduce relapse in alcoholics
16. Naltrexone and coping skills therapy for alcohol dependence. A controlled study
17. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence
18. Pharmacological effects of lisuride shorten, expectations to receive the drug prolong the latency of relapse in cleaned alcoholics
19. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
20. Drugs to decrease alcohol drinking
21. From optimal complexity to the naltrexone extinction of alcoholism
22. Selective extinction of alcohol drinking in rats with decreasing doses of opioid antagonists
23. Long-term alcohol self-administration with repeated alcohol deprivation phases: An animal model of alcoholism?
24. Pharmacological validation of a new animal model of alcoholism
25. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
26. Zur wirksamkeit der therapie bei alkoholabhängigen. Ergebnisse einer meta-analyse
27. Naltrexone in the treatment of alcohol dependence
28. Ritanserin in relapse prevention in abstinent alcoholics: Results from a placebo-controlled double-blind international multicenter trial
29. Flupenthixol decanoate and relapse prevention in alcoholics. Results from a placebo-controlled study
30. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanism at recombinant heteromeric receptors
31. An ethopharmacological approach to the development of drug addiction
32. Animal models of addiction: Models for therapeutical strategies?
33. Social behavior, dominance, and social deprivation of rats determine drug choice
34. From controlled intake to loss of control: The irreversible development of drug addiction in the rat